학술논문
SUCLG2 identified as both a determinator of CSF Aβ1–42 levels and an attenuator of cognitive decline in Alzheimer's disease
Document Type
TEXT
Author
Flier, Wiesje M. van der; Herold, Christine; Ramonet, David; Heilmann, Stefanie; Lewczuk, Piotr; Popp, Julius; Lacour, André; Drichel, Dmitriy; Louwersheimer, Eva; Kummer, Markus P.; Cruchaga, Carlos; Hoffmann, Per; Teunissen, Charlotte; Holstege, Henne; Kornhuber, Johannes; Peters, Oliver; Naj, Adam C.; Chouraki, Vincent; Bellenguez, Céline; Gerrish, Amy; Heun, Reiner; Frölich, Lutz; Hüll, Michael; Buscemi, Lara; Herms, Stefan; Kölsch, Heike; Scheltens, Philip; Breteler, Monique M.; Rüther, Eckart; Wiltfang, Jens; Goate, Alison; Jessen, Frank; Maier, Wolfgang; Heneka, Michael T.; Becker, Tim; Nöthen, Markus M.; http://data.europeana.eu/agent/base/14469; Ramirez, Alfredo
Source
Subject
Language
English
German
German